213 related articles for article (PubMed ID: 12623754)
1. Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.
Krusekopf S; Roots I; Hildebrandt AG; Kleeberg U
Xenobiotica; 2003 Feb; 33(2):107-18. PubMed ID: 12623754
[TBL] [Abstract][Full Text] [Related]
2. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes.
Beedanagari SR; Bebenek I; Bui P; Hankinson O
Toxicol Sci; 2009 Jul; 110(1):61-7. PubMed ID: 19376845
[TBL] [Abstract][Full Text] [Related]
4. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells.
Nakajima M; Iwanari M; Yokoi T
Toxicol Lett; 2003 Sep; 144(2):247-56. PubMed ID: 12927368
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional modulating effects of an indigo dimer (bisindigotin) to CYP1A1 induction in H4IIE cells.
Lai KP; Mak NK; Wei X; Wong RN; Wong MH; Wong CK
Toxicology; 2006 Sep; 226(2-3):188-96. PubMed ID: 16901605
[TBL] [Abstract][Full Text] [Related]
6. Effect of transforming growth factor-beta1 on cytochrome P450 expression: inhibition of CYP1 mRNA and protein expression in primary rat hepatocytes.
Müller GF; Döhr O; El-Bahay C; Kahl R; Abel J
Arch Toxicol; 2000 May; 74(3):145-52. PubMed ID: 10877000
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements.
Yoshinari K; Ueda R; Kusano K; Yoshimura T; Nagata K; Yamazoe Y
Biochem Pharmacol; 2008 Jul; 76(1):139-45. PubMed ID: 18502397
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
9. Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.
Lewis DF; Lake BG; George SG; Dickins M; Eddershaw PJ; Tarbit MH; Beresford AP; Goldfarb PS; Guengerich FP
Toxicology; 1999 Nov; 139(1-2):53-79. PubMed ID: 10614688
[TBL] [Abstract][Full Text] [Related]
10. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
[TBL] [Abstract][Full Text] [Related]
11. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line.
Hukkanen J; Lassila A; Päivärinta K; Valanne S; Sarpo S; Hakkola J; Pelkonen O; Raunio H
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):360-6. PubMed ID: 10696073
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
13. Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract.
Uno S; Dragin N; Miller ML; Dalton TP; Gonzalez FJ; Nebert DW
Free Radic Biol Med; 2008 Feb; 44(4):570-83. PubMed ID: 17997381
[TBL] [Abstract][Full Text] [Related]
14. Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver.
Chang TK; Chen J; Pillay V; Ho JY; Bandiera SM
Toxicol Sci; 2003 Jan; 71(1):11-9. PubMed ID: 12520071
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
Ciolino HP; MacDonald CJ; Yeh GC
Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: induction of CYP1B1 expression by TCDD.
Volotinen M; Mäenpää J; Kankuri E; Oksala O; Pelkonen O; Nakajima M; Yokoi T; Hakkola J
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3099-105. PubMed ID: 19324859
[TBL] [Abstract][Full Text] [Related]
18. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1.
Don MJ; Lewis DF; Wang SY; Tsai MW; Ueng YF
Bioorg Med Chem Lett; 2003 Aug; 13(15):2535-8. PubMed ID: 12852960
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of cytochrome P450 1A1, 1A2, and 1B1, and effects of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners on their hepatic expression in Baikal seal (Pusa sibirica).
Hirakawa S; Iwata H; Takeshita Y; Kim EY; Sakamoto T; Okajima Y; Amano M; Miyazaki N; Petrov EA; Tanabe S
Toxicol Sci; 2007 Jun; 97(2):318-35. PubMed ID: 17383972
[TBL] [Abstract][Full Text] [Related]
20. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
